We investigated the effect of insulin administered as part of a hyperinsulinemic-normoglycemic clamp on protein metabolism after coronary artery bypass grafting (CABG) surgery. Eighteen patients were studied, with nine patients in the control group receiving standard metabolic care and nine patients receiving insulin (5 mU·kg Ϫ1 ·min Ϫ1 ). Whole body glucose production, protein breakdown, synthesis, and oxidation were determined using stable isotope tracer kinetics (L-[1-
THE BODY'S METABOLIC RESPONSE to surgical tissue trauma is characterized by hyperglycemia, enhanced proteolysis, and amino acid (AA) oxidation, resulting in nitrogen loss and negative protein balance (33) . This response to stress was first described almost 80 years ago in four patients with lower limb injuries (7) . Since then the stress response to trauma and surgery has been the focus of much attention in the medical literature. The metabolic response to stress is mediated through neural pathways and the neuroendocrine axis. Various hormones (catecholamines, cortisol) and cytokines [IL-1, IL-6, and tumor necrosis factor (TNF)] are involved in the catabolic response to the surgical tissue trauma. The main goal of this response is restoration of adequate tissue perfusion, oxygenation, and release of substrates for the vital organs (8, 30) . Over the last few decades attempts have been made to find different ways to modulate this exaggerated neurohormonal stress response to improve delivery and utilization of substrates. Some strategies include changing surgical techniques, enhancing anesthetic strategies (neuraxial blockade), and introducing nutritional/metabolic modalities, for instance the hyperinsulinemicnormoglycemic clamp (HNC) technique (5, 21) .
Stress hyperglycemia is the result of increased hepatic gluconeogenesis, glycogenolysis, and peripheral insulin resistance (8) . This rise in blood glucose levels is directly related to the severity of the surgical stress. In patients undergoing cardiac surgery, blood glucose concentrations can increase up to 10 -12 mmol/l for 24 h. The initial rise in blood glucose during the surgical procedure is due to breakdown of hepatic glycogen. As the surgical stress continues and glycogen stores in the liver get consumed and depleted, hepatic gluconeogenesis becomes a significant contributor to glucose blood. AAs derived from muscle protein breakdown are one of the essential substrates in hepatic gluconeogenesis along with lactate, pyruvate, and glycerol. As such, muscle proteolysis, the hallmark of the catabolic response to surgical tissue trauma, is directly related to glucose production (23) . Because even moderately increased blood glucose concentrations are associated with poor clinical outcome after open heart surgery, insulin is being used frequently to maintain normoglycemia (9, 12) . Although the pivotal role of insulin in the regulation of glucose homeostasis is well known, its effect on protein catabolism in this patient population is not (28) .
We recently demonstrated that insulin administered as part of a hyperinsulinemic-normoglycemic clamp during open heart surgery caused significant hypoaminoacidemia (15) . Branchedchain amino acids decreased by almost 70%, while AAs linked with the malate-aspartate cycle were reduced by 30%. As the measurement of static plasma concentrations does not allow any conclusion with regard to underlying dynamic metabolic changes, it remained unclear whether hypoaminoacidemia was a consequence of reduced proteolysis or increased incorporation of AA into newly synthesized proteins.
The purpose of the present study was to investigate the effect of insulin on whole body protein kinetics in patients undergoing cardiac surgery. Our hypothesis was that hypoaminoacidemia in the presence of hyperinsulinemia and normoglycemia is the result of suppressed protein breakdown rather than stimulated protein synthesis.
METHODS

Study Population
With the approval of the Research Ethics Board of the McGill University Health Center we obtained written informed consent from patients scheduled for elective coronary artery bypass grafting (CABG) requiring cardiopulmonary bypass (CPB).
Exclusion criteria included severe malnutrition (weight loss Ͼ20% in the preceding 3 mo, albumin level Ͻ35 g/l, and body mass index Ͻ 20 kg/m 2 ), morbid obesity (body mass index Ͼ 35 kg/m 2 ), chronic liver disease, severe left ventricular dysfunction (left ventricular ejection fraction Ͻ 20%), cancer, and dialysis.
Using a computer program (Plan procedure; SAS software, Cary, NC), consenting patients were randomly allocated to receive insulin or standard metabolic care. The surgeon, nurses, and personnel performing the laboratory analyses were blinded to the patients' group assignment.
Perioperative Care
All patients received standard surgical and anesthetic care as established by the Departments of Anaesthesia and Cardiac Surgery at the Royal Victoria Hospital, McGill University Health Centre. All patients were operated on by the same surgeon (DST). General anesthesia was induced with intravenous midazolam (0.1 mg/kg) and sufentanil (1 g/kg) and maintained with inhaled sevoflurane, intravenous sufentanil (0.5 g·kg Ϫ1 ·h Ϫ1 ), and midazolam (40 g· kg Ϫ1 ·h Ϫ1 ). Hemodynamic monitoring was performed with catheters placed in the right radial artery, the superior vena cava, and the pulmonary artery. Tranexamic acid (2 g bolus followed by continuous infusion of 5 mg·kg Ϫ1 ·h Ϫ1 ) was used as the antifibrinolytic agent during surgery.
Prior to CPB heparin 400 U/kg was given intravenously to obtain an activated clotting time Ͼ 500 s. The ascending aorta and the right atrium were cannulated, the aorta was cross-clamped, and cardioplegia administered. Once coronary anastomoses were sutured and the aortic cross-clamp removed, the patient was separated from CPB. Intravenous dobutamine (2.5 g·kg Ϫ1 ·min Ϫ1 ) was started if the cardiac index remained Ͻ2.2 l·min Ϫ1 ·m Ϫ2 despite adequate fluid resuscitation. Intravenous norepinephrine (1-10 g/min) was used if systolic blood pressure remained consistently Ͻ100 mmHg.
After the administration of protamine (1 mg/100 U heparin) aortic and venous cannulas were removed, homeostasis established, and the pericardium and sternum closed. Patients were transferred to the Intensive Care Unit (ICU) and ventilated to normocapnia. Sedation was maintained using continuous infusions of propofol (10 -25 g·kg Ϫ1 ·min Ϫ1 ) until the end of the study. All subjects were maintained normothermic during the study period.
Study Protocol
Control group. Arterial blood glucose measurements were performed every 30 min using the Accu-chek glucose monitor (Roche Diagnostics). If the blood glucose was Ն10.0 mmol/l, an insulin (Humulin R regular insulin, Eli Lilly, Indianapolis, IN) bolus of 2 U was given followed by the infusion of 2 U/h. The rate of insulin infusion was adjusted according to the following sliding scale: 1) Ͻ4.1 mmol/l, stop insulin infusion and administer 25 ml dextrose 50%; 2) 4.1-6.0 mmol/l, stop insulin infusion; 3) 6.1-10.0 mmol/l, maintain current infusion rate; and 4) Ͼ10.0 mmol/l, increase infusion by 2 U/h.
Insulin group. After obtaining a baseline blood glucose value, a 2 U priming bolus of insulin was given followed by an insulin infusion of 5 mU·kg Ϫ1 ·min Ϫ1 . Additional boluses of insulin were given if the blood glucose remained Ͼ6.0 mmol/l with incremental 2 U of insulin for each 2 mmol/l increase in blood glucose. Ten minutes after commencing the insulin infusion, and when the blood glucose was Յ6.0 mmol/l, a variable continuous infusion of glucose (dextrose 20%) supplemented with potassium (40 meq/l) and phosphate (30 mmol/l) was administered to maintain the blood glucose between 4.0 and 6.0 mmol/l. Insulin infusions were continued until the end of the study period. Arterial blood glucose was measured every 15-20 min.
Leucine Kinetics, Metabolic Substrates, and Hormones
Whole body leucine and glucose metabolism measurements were made under postabsorptive conditions on the day before surgery and, postoperatively, in the ICU (Fig. 1 ). Plasma kinetics of glucose and leucine, i.e., the glucose and leucine rate of appearance (R a), leucine oxidation, and nonoxidative leucine disposal, were determined by a primed constant infusion of tracer quantities of L-[1- 13 2 H2]glucose (0.44 mol·kg Ϫ1 ·min Ϫ1 ). For the determination of 13 CO2 isotope enrichments four expired breath samples were taken after 150, 160, 170, and 180 min of isotope infusion. In addition four blood samples were collected to determine whole body leucine and glucose kinetics. Plasma concentrations of glucose, lactate, amino acids, insulin, and cortisol were determined at 180 min of the pre-and postoperative isotope infusion period.
Blood samples were immediately transferred to a heparinized tube, centrifuged at 4°C, and the resulting plasma was stored at Ϫ70°C until analysis. Breath samples were collected through a mouthpiece in a 3-liter bag and transferred immediately to 10 ml vacutainers until analysis. During the postoperative period, while the patients' lungs were ventilated, expired gases were collected by a one-way valve connected to the ventilator.
13 C]KIC) enrichment was analyzed by electron-impact selected-ion monitoring gas chromatography mass spectrometry (GC/MS) after derivatization to its pentafluorobenzyl ester (Hewlett-Packard 5988A GC/MS, Palo Alto, CA) (18) .
Plasma glucose was derivatized to its penta-acetate compound, and the [6,6- 2 H2]glucose enrichment determined by GC/MS using electron-impact ionization.
Isotopic enrichments were calculated as molecules percent excess (MPE). Expired 13 CO2 enrichment for the calculation of leucine oxidation was analyzed by isotope ratio mass spectrometry (IRMS Analytical Precision AP2, 003, Manchester, UK) (22) .
Plasma glucose was measured by a glucose-oxide method using a Glucose Analyzer 2 (Beckman Instruments, Fullerton, CA). Plasma lactate was measured by an assay founded on lactate oxidase using the Synchron CX system (Beckman Instruments, Fullerton, CA). Plasma cortisol and insulin were analyzed by sensitive and specific doubleantibody radioimmunoassay (Amersham International, Amersham, Bucks, UK).
The concentrations of the following 20 plasma AAs were measured by high-performance liquid chromatography: isoleucine, leucine, valine, lysine, methionine, phenylalanine, threonine, tryptophan, alanine, arginine, asparagine, citrulline, glutamate, glutamine, glycine, histidine, ornithine, proline, serine, and tyrosine. Plasma samples were deproteinized by the addition of 300 l of methanol to 100 l of plasma followed by filtration with 0.2-m filters. All samples were analyzed, in duplicate, using an Agilent 1290 UHPLC (Agilent Technologies, Mississauga, Canada) on an Agilent Poroshell 120 EC-C18 4.6 ϫ 150 mm 2.7 m column. Plasma AAs were analyzed by UHPLC. The AA were detected after precolumn derivatization with o-phthalaldehyde (OPA) and 9-fluorenyl-methyl chloroformate (FMOC). Separation was carried out at a flow rate of 1.5 ml/min under gradient conditions. Mobile phase A was 10 mM Na 2HPO4, 10 mM Na2B4O7, pH 8.2, and mobile phase B was acetonitrile:methanol: water (45:45:10). Initial gradient was 2% B for 0.5 min, then 2% to 57% B in 20 min followed by 5 min reequilibration before the next injection. Primary and secondary AAs were measured by fluorescence with excitation and emission wavelengths of 230 nm and 450 nm, respectively. Data from standards and samples were analyzed using MassHunter B.05 software.
Gaseous Exchange
Oxygen consumption and carbon dioxide production were measured by indirect calorimetry (Datex Instrumentation Deltatrac, Helsinki, Finland) over a period of 20 min toward the end of each isotope infusion study. Average values were taken, with a coefficient of variation (CV) Ͻ10%.
Calculations
Whole body leucine and glucose kinetics were calculated by the conventional isotope dilution technique using a two-pool random model during steady-state conditions (19, 29) . At isotopic steady state the R a of unlabeled substrate in plasma is derived from the plasma isotope enrichment, expressed as MPE, according to the following equation: R a ϭ I·(MPEinf/MPEpl Ϫ 1), where I is the infusion rate of the tracer, MPEinf is the enrichment of the tracer in the infusate, and MPEpl is the tracer enrichment in plasma. The final MPE values represent the mean of all the MPE measurements during each isotopic plateau. Isotopic steady-state conditions were regarded as valid when the CV of the MPE values at isotopic plateau was Ͻ5%.
At isotopic steady state, leucine flux (Q) is quantified by the following formula: Q ϭ S ϩ O ϭ B ϩ I, where S is the rate of synthesis of protein from leucine, O is the rate of oxidation, B is protein breakdown, and I is the dietary intake. Furthermore Q is equal to R a (Ra ϭ B ϩ I) and the rate of disappearance (Rd; Rd ϭ S ϩ O). When tracer studies are done in fasting states, leucine flux equals B. The rate of protein synthesis is calculated by subtracting leucine oxidation from leucine flux (S ϭ Q Ϫ O). Protein balance is calculated as protein synthesis minus leucine R a with positive values indicating anabolism and negative values catabolism. Plasma ␣-[1-13 C]KIC is used to calculate the flux and oxidation of leucine. The ␣-KIC is formed intracellularly from leucine and is released into the systemic circulation. It reflects the intracellular precursor pool enrichment more accurately than plasma leucine itself (20) . In the calculation of leucine oxidation, a correction factor of 0.76 was used in the fasted state to account for the fraction of 13 CO2 released from leucine but retained within slow turnover rate pools of the body (19) .
Under postabsorptive conditions the R a of glucose represents endogenous production of glucose. During glucose infusion, endogenous Ra of glucose was calculated by subtracting the glucose infusion rate from the total Ra of glucose.
In the calculation of leucine oxidation in patients receiving the hyperinsulinemic-normoglycemic clamp, correction was made for the dilution effect of 13 CO2 due to the low 13 C content of the glucose infusion. The correctional factor obtained in two additional clamp studies without L-[1-
13 C]leucine was 10%.
Statistical Analysis
The primary end point of the study was the Ra of leucine on the first postoperative day. Based on previously observed differences in branched-chain amino acids, we expected a difference of at least 40% between the two groups. To detect this difference with a type I error of 5% and a power of at least 80%, nine patients in each group were required.
Patients' characteristics and perioperative data were compared using the unpaired Student's t-test, chi-square test, and Fisher's exact test where appropriate. Blood glucose levels at different time points between the two groups were compared using linear mixed models. Unpaired Student's t-test was used to compare AA concentrations between the two groups. Paired Student's test was used to assess the differences in the AA levels within the same group. The difference in whole body leucine kinetics, gaseous exchange, and plasma concentrations of hormones and substrates between the two groups was analyzed by using ANOVA for repeated measurements (before and after surgery). The relationship between Ra leucine and endogenous Ra glucose was evaluated by the correlation coefficient. All data are presented as means Ϯ SD unless otherwise specified. Statistical significance was set as P Ͻ 0.05. All P values presented are twotailed. All statistical analyses were performed using SAS 9.2 (SAS Institute).
RESULTS
We enrolled and studied 18 patients with 9 in the control group and 9 in the insulin group. Baseline characteristics and surgical data were similar in the two groups (Table 1) .
Blood glucose concentrations progressively rose in the control group without exceeding 10 mmol/l (Fig. 2) . Hence no insulin was required. In the insulin group blood glucose levels were kept in the normoglycemic range between 4.0 and 6.0 mmol/l (Fig. 2) . No episode of hypoglycemia (blood glucose Ͻ 3.5 mmol/l) was observed. (Figs.  3, 4 , and 5). There was no difference in preoperative leucine and glucose kinetics between groups. Postoperative R a leucine and protein synthesis significantly decreased in patients receiving insulin and glucose, while protein kinetics did not change in the control group (Table 2 ). There was a nonsignificant decrease in leucine oxidation and balance after surgery in the insulin group. Endogenous glucose production postoperatively decreased in the insulin group and remained unchanged in the control group (Table 2) . A positive correlation between endogenous R a glucose and R a leucine was observed in patients receiving insulin (Fig. 6, r 2 ϭ 0.385). Whole body O 2 consumption remained unchanged postoperatively in both groups. Whole body CO 2 production and respiratory quotient increased after surgery in the insulin group indicating stimulated glucose oxidation (Table 3) .
Lactate concentrations increased in both groups to a similar extent after surgery (control group preoperatively 0.9 Ϯ 0.2, postoperatively 1.6 Ϯ 0.8 mmol/l; insulin group preoperatively 0.7 Ϯ 0.3, postoperatively 1.3 Ϯ 0.3 mmol/l). Preoperative plasma insulin (control group 51 Ϯ 24 pmol/l, insulin group 45 Ϯ 17 pmol/l) and cortisol (control group 173 Ϯ 74 nmol/l, Values are means Ϯ SD. Ra, rate of appearance. P value was determined by ANOVA for repeated measures. *Probability that values change after surgery. †Probability that values are different between the two groups. ‡Probability that postoperative changes are different between the two groups. insulin group 131 Ϯ 57 nmol/l) concentrations were similar in the two groups. In the insulin group plasma insulin levels were significantly elevated compared with patients in the control group (3,647 Ϯ 532 pmol/l vs. 52 Ϯ 35 pmol/l, P Ͻ 0.001). Plasma cortisol levels increased postoperatively without showing any difference between the two groups (control group 793 Ϯ 381 nmol/l, insulin group 620 Ϯ 251 nmol/l), indicating similar effects of anesthesia and analgesia on the endocrine response to surgical stress. Plasma AA concentrations were similar between the groups at baseline. In the insulin group, the plasma concentrations of 13 of 20 essential (EAA) and nonessential AA (NEAA) decreased to a significantly greater extent than in the control group (Table 4) .
DISCUSSION
The results of the present study demonstrate that insulin, administered at 5 mU·kg Ϫ1 ·min Ϫ1 as part of a normoglycemic clamp, reduces whole body protein breakdown by 20% and synthesis by 19% after open heart surgery. This decrease in proteolysis in the presence of supraphysiological hyperinsulinemia (plasma insulin at 3,600 pmol/l) was less pronounced than that previously reported in healthy subjects. Fukagawa et al. (11) showed a 25% lower leucine rate of appearance during the infusion of 30 mU·m Ϫ2 ·min Ϫ1 insulin and a plasma insulin level at 520 pmol/l, and a 30% inhibition of protein breakdown with the infusion of 400 mU·m Ϫ2 ·min Ϫ1 insulin and a plasma insulin concentration of 16,600 pmol/l. Tessari et al. (27) Values are means Ϯ SD. V O2, whole body oxygen consumption; V CO2, whole body carbon dioxide production; RQ, respiratory quotient. P value was determined by ANOVA for repeated measures. *Probability that values change after surgery. †Probability that values are different between the two groups. ‡Probability that postoperative changes are different between the two groups. Similar to the observed change in protein breakdown, whole body protein synthesis decreased in patients receiving insulin, most likely a consequence of reduced substrate supply, i.e., hypoaminoacidemia. As demonstrated in a previous study in cardiac surgery insulin administration led to a 30 -60% decrease in the circulating concentrations of most AAs (15) . By contrast, patients with lung cancer and healthy young subjects showed increased protein synthesis and positive protein balance if hypoaminoacidemia was avoided by exogenous provision of amino acids (6, 32) suggesting that the anabolic action of insulin requires adequate substrate supply (1, 4) . This assumption is supported by studies in burn patients showing anabolic effects of insulin on muscle protein synthesis when iso-or hyperaminoacidemia was maintained (14) .
Surgical stress induces transient insulin resistance, which leads to an increase in hyperglycemia and an inability of insulin to inhibit proteolysis via the phosphatidylinositol-3-kinase (PI3K)/Akt pathway that activates two important ubiquitin protein ligases: Atrogen-1/MAFbx and MURF-1 (26, 28, 31) . High-dose insulin, through its membrane receptors, overcomes insulin resistance and thereby decreases whole body protein wasting and lowers plasma AA levels. The lack of circulating AAs is one of the main reasons why protein synthesis is inhibited in the presence of insulin. However, this can be overcome by the simultaneous provision of AAs (2, 6, 14) .
Although the present study was not designed to dissect the mechanisms responsible for the metabolic effects of insulin, two additional factors may have contributed to the metabolic effects of HNC: administration of glucose as part of the normoglycemic clamp and strict maintenance of normoglycemia. Patients in the hyperinsulinemic-normoglycemic clamp group received glucose at an average dose of 3.6 Ϯ 0.7 mg·kg Ϫ1 ·min Ϫ1 . The administration of that amount of glucose inhibits gluconeogenesis and, thus, lowers the need for glucoplastic AAs. In fact, similar to previous reports in surgical patients a positive correlation between protein breakdown and endogenous glucose production was observed in our patients receiving insulin and glucose (24) .
Hyperglycemia, per se, has been shown to exacerbate protein catabolism during critical illness and may blunt the anabolic response to feeding. In burn patients the extent of net muscle protein catabolism increased proportionally with the level of blood glucose (13) . In contrast active glycemic control was associated with less nitrogen loss in the critically ill (16) . After major cancer surgery, hyperglycemia induced by parenteral nutrition was accompanied by muscle protein catabolism, while maintenance of normoglycemia restored a neutral protein balance in these patients (3) . The mechanism underlying the anticatabolic influence of normoglycemia can be attributed to the stimulation of skeletal muscle protein synthesis and the decrease in extramuscular tissue proteolysis (3, 10) . Hyperglycemia has been shown to be associated with a 50% greater skeletal leucine oxidation rate when compared with normoglycemia (10) . Moreover, hyperglycemia prompts the activation of the enzyme branched-chain ␣-ketoacid dehydrogenase, which catalyzes the initial irreversible step in the leucine oxidation pathway (25) . A greater intracellular leucine availability caused by the inhibition of leucine oxidation could, therefore, directly stimulate protein synthesis (17) .
In summary, we observed that achieving supraphysiological levels of exogenous insulin while maintaining normoglycemia after CABG surgery decreased whole body protein breakdown and synthesis. However, net protein balance remained negative. It remains to be investigated whether anabolism can be achieved in this patient population by the avoidance of hypoaminoacidemia, by simultaneous infusion of amino acids.
